Suppr超能文献

莲花凝集素对硫酸软骨素蛋白聚糖诱导的轴突生长抑制的阻断作用

Blockade of chondroitin sulfate proteoglycans-induced axonal growth inhibition by LOTUS.

作者信息

Kurihara Yuji, Saito Yu, Takei Kohtaro

机构信息

Molecular Medical Bioscience Laboratory, Department of Medical Life Science, Yokohama City University Graduate School of Medical Life Science, Suehiro-cho 1-7-29, Tsurumi-ward, Yokohama 230-0045, Japan.

Molecular Medical Bioscience Laboratory, Department of Medical Life Science, Yokohama City University Graduate School of Medical Life Science, Suehiro-cho 1-7-29, Tsurumi-ward, Yokohama 230-0045, Japan.

出版信息

Neuroscience. 2017 Jul 25;356:265-274. doi: 10.1016/j.neuroscience.2017.05.034. Epub 2017 May 30.

Abstract

Chondroitin sulfate proteoglycans (CSPGs) are axon growth inhibitors in the glial scar, and restrict axon regeneration following damage to the adult mammalian central nervous system. CSPGs have recently been identified as functional ligands for Nogo receptor-1 (NgR1), which is the common receptor for Nogo proteins, myelin-associated glycoprotein (MAG), oligodendrocyte myelin glycoprotein (OMgp) and B lymphocyte stimulator (BLyS). We have previously reported that through its binding to NgR1, lateral olfactory tract usher substance (LOTUS) suppresses Nogo, MAG, OMgp, and BLyS-induced axon growth inhibition. However, it remains unknown whether LOTUS also exerts this suppressive action on CSPG-induced axon growth inhibition. LOTUS overexpression rescued CSPG-induced growth cone collapse and neurite outgrowth inhibition in cultured dorsal root ganglion neurons, which only weakly express endogenous LOTUS. In cultured olfactory bulb neurons, which endogenously express LOTUS, the growth cone was insensitive to CSPG-induced collapse, but was sensitive to collapse induced by CSPGs in lotus-deficient mice. Our data demonstrate that LOTUS suppresses CSPG-induced axon growth inhibition, suggesting that LOTUS may represent a promising therapeutic agent for promoting axon regeneration.

摘要

硫酸软骨素蛋白聚糖(CSPGs)是胶质瘢痕中的轴突生长抑制剂,在成年哺乳动物中枢神经系统受损后会限制轴突再生。CSPGs最近被鉴定为Nogo受体-1(NgR1)的功能性配体,NgR1是Nogo蛋白、髓磷脂相关糖蛋白(MAG)、少突胶质细胞髓磷脂糖蛋白(OMgp)和B淋巴细胞刺激因子(BLyS)的共同受体。我们之前报道过,外侧嗅束引导物质(LOTUS)通过与NgR1结合,可抑制Nogo、MAG、OMgp和BLyS诱导的轴突生长抑制。然而,LOTUS是否也对CSPG诱导的轴突生长抑制发挥这种抑制作用仍不清楚。LOTUS过表达挽救了培养的背根神经节神经元中CSPG诱导的生长锥塌陷和神经突生长抑制,这些神经元仅微弱表达内源性LOTUS。在内源性表达LOTUS的培养嗅球神经元中,生长锥对CSPG诱导的塌陷不敏感,但对LOTUS缺陷小鼠中CSPG诱导的塌陷敏感。我们的数据表明,LOTUS可抑制CSPG诱导的轴突生长抑制,这表明LOTUS可能是一种有前景的促进轴突再生的治疗药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验